Location History:
- Chiba, JP (2009)
- Tokyo, JP (2008 - 2012)
Company Filing History:
4 out of 257 
4 out of 389 
1 out of 73 
Years Active: 2008-2012
Title: Shinsuke Hiki: Innovator in Neurodegenerative Disease Treatment
Introduction
Shinsuke Hiki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurodegenerative diseases. With a total of 5 patents to his name, Hiki's work focuses on innovative compounds that target tau protein kinase 1 hyperactivity.
Latest Patents
Hiki's latest patents include groundbreaking compounds aimed at treating diseases such as Alzheimer's. One notable patent is for 6-(pyridinyl)-4-pyrimidone derivatives, which serve as tau protein kinase 1 inhibitors. This compound is represented by a specific formula and is designed to be used in the preventive and therapeutic treatment of neurodegenerative diseases. Another significant patent is for a 2-morpholino-4-pyrimidone compound, which also targets tau protein kinase 1 hyperactivity. This compound is similarly represented by a specific formula and is intended for the same therapeutic applications.
Career Highlights
Throughout his career, Shinsuke Hiki has worked with notable companies in the pharmaceutical industry. He has been associated with Mitsubishi Tanabe Pharma Corporation and Sanofi-Aventis, where he has contributed to various research and development projects. His expertise in the field has allowed him to make substantial advancements in drug development.
Collaborations
Hiki has collaborated with esteemed colleagues such as Fumiaki Uehara and Kazutoshi Watanabe. These collaborations have further enhanced his research and innovation in the pharmaceutical sector.
Conclusion
Shinsuke Hiki is a distinguished inventor whose work has the potential to significantly impact the treatment of neurodegenerative diseases. His innovative compounds and collaborations highlight his commitment to advancing medical science.